Phase Ib/Ii Study of Lee011 (Cdk4/6 Inhibitor) and Lgx818 (Braf Inhibitor) in Braf-Mutant Melanoma - Concepedia

Concepedia

Publication | Closed Access

Phase Ib/Ii Study of Lee011 (Cdk4/6 Inhibitor) and Lgx818 (Braf Inhibitor) in Braf-Mutant Melanoma

20

Citations

0

References

2014

Year

Michael Taylor, Jeff Sosman, R. Gonzalez, Matteo S. Carlino, Muaiad Kittaneh, Martijn P. Lolkema, Wilson H. Miller, Aída Marino, V. Zhang, SG Bhansali,

Annals of Oncology

OncologyMedicineMelanomaBraf InhibitorPhase Ib/ii StudyCell BiologyCancer BiologyRadiation OncologyCancer ResearchTumor BiologyBraf-mutant Melanoma

No additional data available for this publication yet. Check back later!